KS drug goes to FDA. Food and Drug Administration.
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D000287:Administration, Topical; D002986:Clinical Trials as Topic; D017277:Drug Approval; D006801:Humans; D012176:Retinoids / Q000008:administration & dosage*; D012514:Sarcoma, Kaposi / Q000188:drug therapy*; D012878:Skin Neoplasms / Q000188:drug therapy*; D014481:United States; D014486:United States Food and Drug Administration
D012176:Retinoids